
Linneo Health | Pharmaceutical Cannabis
Global leader in the research, EU-GMP certified manufacture and supply of medicinal cannabis flowers, extracts and products to partners developing cannabis-based therapies for patients in need.
Linneo provides the highest quality medicinal cannabis to improve lives. The Europe leader in the research, manufacture and B2B supply of medical cannabis flowers, extracts and services for pharmaceutical industry.
General Information
Location: Murcia, Spain
Roles: Operations | Engineering | Projects | Building | Cultivation | Postharvest | Quality Control | R&D | Industrial Maintenance | HS&E
Direct report to the Board
Product: API (active pharmaceutical ingredient) Medicinal Cannabis dry flowers, GACP biomass, extracts and derivates
CAPEX >35M €
Infrastructure: 3,0ha hi-tec greenhouse, GMP Postharvest Area, Quality Control Laboratory, Water Purification Plant, Water Treatment Plant, 100ha Outdoor Cultivation
Installed power: 3,5MW
Company size: >120 employees
Revenues: +10M €/year
Director of Production
October 2019 - Current (+5 years)
Track Record
Production:
Greenhouse Cultivation for dried flowers:
6x 2.000m² Flowering Areas
Outdoor Cultivation (GACP) for dried flowers and biomass for extraction:
Up to 100ha of cultivation surface
Industrial Products:
THC Crude extract 40-70% (full spectrum)
THC Extract standarized on MTC oil
CBD Crude extract 40-55% (full spectrum)
CBD Extract standarized on MTC oil
THC:CBD Extract standarized on MTC oil
THC API >95%
Achivements
Top 3 European Medicinal Cannabis Producer
In-house EU-GLP Quality Control Lab
Biggest Extraction Capabilities in Europe
CAGR growth of 150% in the last 3 years
Certifications
GACP (indoor and outdoor, cultivation and harvest)
GLP Clinical Laboratory
EU-GMP Part I and Part II
Awards
First tender award, making Linneo exclusive supplier into Italy






























